DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Mazor Y, Almog R, Kopylov U. et al.
Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohnʼs disease.
Aliment Pharmacol Ther 2014;
40: 620-628
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.